Information:
Fel:
ID
24154
Beskrivning
Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00577122
Länk
https://clinicaltrials.gov/show/NCT00577122
Nyckelord
Versioner (1)
- 2017-07-26 2017-07-26 -
Uppladdad den
26 juli 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Estrogen Receptor-negative Breast Cancer NCT00577122
Eligibility Estrogen Receptor-negative Breast Cancer NCT00577122
- StudyEvent: Eligibility
Similar models
Eligibility Estrogen Receptor-negative Breast Cancer NCT00577122
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Breast adenocarcinoma | Measurable Disease Recurrent Local | Neoplasm Metastasis
Item
histologically or cytologically confirmed adenocarcinoma of the breast with measurable locally recurrent or metastatic disease
boolean
C0858252 (UMLS CUI [1])
C1513041 (UMLS CUI [2,1])
C2945760 (UMLS CUI [2,2])
C0205276 (UMLS CUI [2,3])
C0027627 (UMLS CUI [3])
C1513041 (UMLS CUI [2,1])
C2945760 (UMLS CUI [2,2])
C0205276 (UMLS CUI [2,3])
C0027627 (UMLS CUI [3])
Primary tumor Estrogen receptor negative Progesterone receptor negative
Item
primary tumor must be er negative and pr negative
boolean
C0677930 (UMLS CUI [1,1])
C0279756 (UMLS CUI [1,2])
C0279766 (UMLS CUI [1,3])
C0279756 (UMLS CUI [1,2])
C0279766 (UMLS CUI [1,3])
Postmenopausal state
Item
patients must be post-menopausal
boolean
C0232970 (UMLS CUI [1])
Chemotherapy Regimen Quantity Recurrent disease | Chemotherapy Regimen Quantity Neoplasm Metastasis
Item
patients may have had up to 3 prior chemotherapy regimens for recurrent/metastatic disease
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0277556 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0027627 (UMLS CUI [2,3])
C1265611 (UMLS CUI [1,2])
C0277556 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0027627 (UMLS CUI [2,3])
Organ function Laboratory studies
Item
adequate organ function as evidenced by laboratory studies outlined in section 3.6 of the protocol
boolean
C0678852 (UMLS CUI [1,1])
C0681827 (UMLS CUI [1,2])
C0681827 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain Asymptomatic Treated | STEROID TREATMENT CHRONIC Requirement Absent
Item
patients with treated, asymptomatic brain metastases are eligible provided chronic steroid therapy is not required
boolean
C0220650 (UMLS CUI [1,1])
C0231221 (UMLS CUI [1,2])
C1522326 (UMLS CUI [1,3])
C0749016 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0231221 (UMLS CUI [1,2])
C1522326 (UMLS CUI [1,3])
C0749016 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Pleural effusion Extensive | Ascites
Item
patients must not have extensive pleural effusion or ascites
boolean
C0032227 (UMLS CUI [1,1])
C0205231 (UMLS CUI [1,2])
C0003962 (UMLS CUI [2])
C0205231 (UMLS CUI [1,2])
C0003962 (UMLS CUI [2])
Deep Vein Thrombosis | Pulmonary Embolism
Item
patients must not have history of dvt or pulmonary embolism w/in past 12 mo
boolean
C0149871 (UMLS CUI [1])
C0034065 (UMLS CUI [2])
C0034065 (UMLS CUI [2])
Chemotherapy | Hormone Therapy
Item
patients must not have had chemotherapy or hormonal therapy within 2 weeks of study entry
boolean
C0392920 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
C0279025 (UMLS CUI [2])
Therapeutic radiology procedure
Item
patients must not have had radiation therapy within 1 week of study entry.
boolean
C1522449 (UMLS CUI [1])